Dr. Noor Hussam Abu-FarsakhGastroenterologist & Hepatologist
←Back to home

Home/Articles

Fatty liver: is it serious, and how is it treated?

5 min read

Medically reviewed by Dr. Noor Hussam Abu-Farsakh — Gastroenterologist & Hepatologist

Fatty liver is the build-up of fat in liver cells. It is now the most common liver disease, closely linked to excess weight, diabetes and high lipids, and is now called metabolic dysfunction-associated steatotic liver disease (MASLD). Most cases are mild, but some progress to inflammation and fibrosis if untreated.

Who is at risk?

  • Excess weight, especially around the waist.
  • Type 2 diabetes or insulin resistance.
  • High triglycerides or cholesterol.
  • High blood pressure.

Symptoms

Usually none — fatty liver is often found by chance on ultrasound or raised liver enzymes. Some people feel tired or a heaviness in the upper right abdomen.

How is it assessed?

The key question is not the fat itself but the degree of fibrosis. This is estimated with simple blood-test scores (such as FIB-4) and, when needed, liver stiffness measurement (FibroScan).

Treatment

Lifestyle change is the cornerstone: losing 7–10% of body weight clearly improves fat and inflammation, and may improve fibrosis. A balanced diet (such as Mediterranean), fewer sugars and sweet drinks, and at least 150 minutes of activity a week are recommended.

Controlling diabetes, lipids and blood pressure is essential, and medication is used in selected cases.

When to see a liver specialist

  • Persistently raised liver enzymes.
  • Tests suggesting fibrosis.
  • Diabetes with fatty liver.
  • Yellow eyes, abdominal or leg swelling.
Key takeaways
  • Fatty liver is common and often silent, but reversible.
  • Assessing fibrosis matters more than the fat itself.
  • Gradual weight loss and exercise are the most important treatment.

This article is for health education and does not replace medical advice.

References
  1. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81:492–542.
  2. Rinella ME, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77:1797–1835.
  3. Rinella ME, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023.

Appointments

Book your consultation.

Clinic hoursSaturday – Thursday10:00 AM – 4:00 PMFriday: closed
LocationSaudi Hospital, Outpatient Clinics, Ground Floor, Khalda, AmmanOpen in Google Maps ↗
Facebook↗
Booking in advance by WhatsApp or phone is recommended.